Clinical Trials
39 trialsINCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas
Pediatric Brain Tumor Consortium
STEAM
European Organisation for Research and Treatment of Cancer - EORTC
MIRAGE
European Organisation for Research and Treatment of Cancer - EORTC
Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma
European Organisation for Research and Treatment of Cancer - EORTC
Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme
Canadian Cancer Trials Group
A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression
Canadian Cancer Trials Group
Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme
Canadian Cancer Trials Group
mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme
Canadian Cancer Trials Group
Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
Eastern Cooperative Oncology Group
High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Eastern Cooperative Oncology Group
Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
Children's Oncology Group
Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
Radiation Therapy Oncology Group
RTOG 0913
Radiation Therapy Oncology Group
Bevacizumab and Lomustine for Recurrent GBM
European Organisation for Research and Treatment of Cancer - EORTC
Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme
Radiation Therapy Oncology Group
Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
Radiation Therapy Oncology Group
Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
Radiation Therapy Oncology Group
SarCNU in Treating Patients With Recurrent Malignant Glioma
Canadian Cancer Trials Group
Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma
Radiation Therapy Oncology Group
TAVAREC
European Organisation for Research and Treatment of Cancer - EORTC
Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
European Organisation for Research and Treatment of Cancer - EORTC
p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors
Pediatric Brain Tumor Consortium
Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme
European Organisation for Research and Treatment of Cancer - EORTC
Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma
Radiation Therapy Oncology Group
SWIGLI
Fondation Ophtalmologique Adolphe de Rothschild
Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme
Radiation Therapy Oncology Group
Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
Children's Oncology Group
Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Radiation Therapy Oncology Group
Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
Radiation Therapy Oncology Group
S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma
SWOG Cancer Research Network
Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma
European Organisation for Research and Treatment of Cancer - EORTC
Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme
European Organisation for Research and Treatment of Cancer - EORTC
Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
European Organisation for Research and Treatment of Cancer - EORTC
Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme
European Organisation for Research and Treatment of Cancer - EORTC
Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
European Organisation for Research and Treatment of Cancer - EORTC
Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma
European Organisation for Research and Treatment of Cancer - EORTC
Imatinib Mesylate in Treating Patients With Gliomas
European Organisation for Research and Treatment of Cancer - EORTC
Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery
European Organisation for Research and Treatment of Cancer - EORTC
Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme
European Organisation for Research and Treatment of Cancer - EORTC